Zacks upgraded Adicet Bio (ACET) to a Rank #2 (Buy), signaling increased confidence in the company's earnings prospects. The upgrade is likely to lift sentiment and could push the stock higher in the near term, with potential single-digit percentage moves on the news.
Zacks upgraded Adicet Bio (ACET) to a Rank #2 (Buy), signaling increased confidence in the company's earnings prospects. The upgrade is likely to lift sentiment and could push the stock higher in the near term, with potential single-digit percentage moves on the news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
